Fujifilm Diosynth Biotechnologies will expand its services in mammalian cell line development/process development, and add a multi-product cGMP facility at its Billingham, UK site. The first phase has seen development of the company’s cell line and process/analytical development facilities, including addition of the latest high throughput technologies to enable rapid transition of biologics from discovery to clinic. This is supported by a significant increase of the Mammalian Development Group ...